Lung Kee Group Holdings Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Yuk Lung Siu

Algemeen directeur

HK$9.3m

Totale compensatie

Percentage CEO-salaris	90.1%
Dienstverband CEO	31.9yrs
Eigendom CEO	3.7%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	18.4yrs

Recente managementupdates

What We Learned About Lung Kee (Bermuda) Holdings' (HKG:255) CEO Compensation

Dec 20

Recent updates

Lung Kee (Bermuda) Holdings Limited's (HKG:255) Business Is Trailing The Industry But Its Shares Aren't

Jan 09

Lung Kee (Bermuda) Holdings (HKG:255) Is Paying Out Less In Dividends Than Last Year

Aug 28

Lung Kee (Bermuda) Holdings (HKG:255) Will Pay A Smaller Dividend Than Last Year

May 30

Lung Kee (Bermuda) Holdings' (HKG:255) Dividend Will Be Reduced To HK$0.06

Apr 04

Lung Kee (Bermuda) Holdings (HKG:255) Is Increasing Its Dividend To HK$0.15

Aug 29

Something To Consider Before Buying Lung Kee (Bermuda) Holdings Limited (HKG:255) For The 9.1% Dividend

Mar 29

What These Trends Mean At Lung Kee (Bermuda) Holdings (HKG:255)

Mar 09

Estimating The Intrinsic Value Of Lung Kee (Bermuda) Holdings Limited (HKG:255)

Feb 16

Here's What Lung Kee (Bermuda) Holdings Limited's (HKG:255) Shareholder Ownership Structure Looks Like

Jan 29

If You Had Bought Lung Kee (Bermuda) Holdings (HKG:255) Shares Three Years Ago You'd Have A Total Return Of Negative 12%

Jan 10

What We Learned About Lung Kee (Bermuda) Holdings' (HKG:255) CEO Compensation

Dec 20

Are Dividend Investors Making A Mistake With Lung Kee (Bermuda) Holdings Limited (HKG:255)?

Dec 01

Here's What's Concerning About Lung Kee (Bermuda) Holdings (HKG:255)

Nov 18

Analyse CEO-vergoeding

Hoe is Yuk Lung Siu's beloning veranderd ten opzichte van Lung Kee Group Holdings's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	-HK$65m
Mar 31 2024	n/a	n/a	-HK$69m
Dec 31 2023	HK$9m	HK$8m	-HK$72m
Sep 30 2023	n/a	n/a	-HK$65m
Jun 30 2023	n/a	n/a	-HK$57m
Mar 31 2023	n/a	n/a	-HK$20m
Dec 31 2022	HK$9m	HK$8m	HK$16m
Sep 30 2022	n/a	n/a	HK$88m
Jun 30 2022	n/a	n/a	HK$161m
Mar 31 2022	n/a	n/a	HK$194m
Dec 31 2021	HK$10m	HK$8m	HK$228m
Sep 30 2021	n/a	n/a	HK$225m
Jun 30 2021	n/a	n/a	HK$222m
Mar 31 2021	n/a	n/a	HK$202m
Dec 31 2020	HK$10m	HK$8m	HK$181m
Sep 30 2020	n/a	n/a	HK$164m
Jun 30 2020	n/a	n/a	HK$146m
Mar 31 2020	n/a	n/a	HK$148m
Dec 31 2019	HK$10m	HK$8m	HK$149m
Sep 30 2019	n/a	n/a	HK$133m
Jun 30 2019	n/a	n/a	HK$117m
Mar 31 2019	n/a	n/a	HK$144m
Dec 31 2018	HK$11m	HK$8m	HK$171m
Sep 30 2018	n/a	n/a	HK$211m
Jun 30 2018	n/a	n/a	HK$251m
Mar 31 2018	n/a	n/a	HK$265m
Dec 31 2017	HK$12m	HK$8m	HK$278m

Compensatie versus markt: De totale vergoeding ($USD 1.20M ) Yuk Lung } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 233.11K ).

Compensatie versus inkomsten: De vergoeding van Yuk Lung is gestegen terwijl het bedrijf verliesgevend is.

CEO

Yuk Lung Siu (70 yo)

31.9yrs

Tenure

HK$9,324,000

Compensatie

Mr. Yuk Lung Siu has been the Managing Director of Lung Kee Group Holdings Limited (formerly known as Lung Kee (Bermuda) Holdings Limited) since December 1992. Mr. Siu Co-founded Lung Kee Group Holdings Li...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Tit Lung Siu	Co-Founder & Executive Chairman	31.9yrs	HK$9.32m	3.68% HK$ 26.0m
Yuk Lung Siu	Co-Founder	31.9yrs	HK$9.32m	3.68% HK$ 26.0m
Chung Ho Ting	Executive Director	16.6yrs	HK$2.85m	0.11% HK$ 806.4k
Yuk Tung Siu	Executive Director	7.8yrs	HK$2.13m	0.013% HK$ 89.6k
Yu Hang Siu	Executive Director	7.8yrs	HK$1.94m	0.17% HK$ 1.2m
Lung Shing Wai	Company Secretary & Executive Director	31.9yrs	HK$2.93m	0.61% HK$ 4.3m
Lee Joo Hai	Independent Non-Executive Director	20.2yrs	HK$436.00k	0.047% HK$ 336.0k
Tat Yee Lee	Independent Non-Executive Director	31.9yrs	HK$436.00k	0.024% HK$ 168.0k
Hak Kun Wong	Independent Non-Executive Director	6.4yrs	HK$452.00k	geen gegevens
Lamei He	Independent Non Executive Director	2.7yrs	HK$389.00k	geen gegevens

18.4yrs

Gemiddelde duur

68yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 255 zijn ervaren en ervaren (gemiddelde ambtstermijn van 18.4 jaar).

Lung Kee Group Holdings Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Lung Kee (Bermuda) Holdings Limited, Annual General Meeting, May 27, 2024

Less than half of directors are independent

Less than half of directors are independent

Lung Kee (Bermuda) Holdings Limited Appoints Ms. He Lamei as Independent Non-Executive Director, Member of Each of the Audit Committee, the Nomination Committee and the Remuneration Committee

What We Learned About Lung Kee (Bermuda) Holdings' (HKG:255) CEO Compensation

Recent updates

Lung Kee Group Holdings Limited Declares Interim Dividend for the Six Months Ended 30 June 2024, Payable on 24 September 2024

Lung Kee Group Holdings Limited to Report First Half, 2024 Results on Aug 23, 2024

Lung Kee (Bermuda) Holdings Limited Approves Final Dividend for the Year Ended 31 December, 2023

Lung Kee (Bermuda) Holdings Limited, Annual General Meeting, May 27, 2024

Lung Kee (Bermuda) Holdings Limited to Report Fiscal Year 2023 Results on Mar 22, 2024

Lung Kee (Bermuda) Holdings Limited Announces Voluntary Delist of Shares

Lung Kee (Bermuda) Holdings Limited Announces Voluntary Delist of Shares

Lung Kee (Bermuda) Holdings Limited's (HKG:255) Business Is Trailing The Industry But Its Shares Aren't

Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Year Ended 31 December 2023

Upcoming dividend of HK$0.05 per share at 7.6% yield

Lung Kee (Bermuda) Holdings (HKG:255) Is Paying Out Less In Dividends Than Last Year

First half 2023 earnings released: HK$0.05 loss per share (vs HK$0.065 profit in 1H 2022)

Lung Kee (Bermuda) Holdings Limited to Report First Half, 2023 Results on Aug 25, 2023

Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023

Lung Kee (Bermuda) Holdings (HKG:255) Will Pay A Smaller Dividend Than Last Year

Lung Kee (Bermuda) Holdings Limited Approves Final Dividend for the Year Ended 31 December, 2022

Upcoming dividend of HK$0.06 per share at 5.9% yield

Lung Kee (Bermuda) Holdings' (HKG:255) Dividend Will Be Reduced To HK$0.06

Full year 2022 earnings released: EPS: HK$0.025 (vs HK$0.36 in FY 2021)

Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Year Ended 31 December 2022

Now 22% undervalued after recent price drop

Less than half of directors are independent

Now 22% undervalued after recent price drop

Upcoming dividend of HK$0.06 per share

Lung Kee (Bermuda) Holdings Limited Announces Interim Dividend for the Six Months Ended June 30, 2022, Payable on September 27, 2022

First half 2022 earnings released: EPS: HK$0.065 (vs HK$0.17 in 1H 2021)

Lung Kee (Bermuda) Holdings Limited to Report First Half, 2022 Results on Aug 26, 2022

Investor sentiment deteriorated over the past week

Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Six Months Ended June 30, 2022

Lung Kee (Bermuda) Holdings Limited Declares Final Dividend

Upcoming dividend of HK$0.20 per share

Less than half of directors are independent

Lung Kee (Bermuda) Holdings Limited Appoints Ms. He Lamei as Independent Non-Executive Director, Member of Each of the Audit Committee, the Nomination Committee and the Remuneration Committee

Upcoming dividend of HK$0.15 per share

First half 2021 earnings released: EPS HK$0.17 (vs HK$0.11 in 1H 2020)

Lung Kee (Bermuda) Holdings (HKG:255) Is Increasing Its Dividend To HK$0.15

Investor sentiment improved over the past week

Lung Kee (Bermuda) Holdings Limited Approves and Declares Final Special Dividend

Upcoming dividend of HK$0.28 per share

Full year 2020 earnings released: EPS HK$0.29 (vs HK$0.24 in FY 2019)

Something To Consider Before Buying Lung Kee (Bermuda) Holdings Limited (HKG:255) For The 9.1% Dividend

Lung Kee (Bermuda) Holdings Limited Recommends Final Special Dividend for the Year Ended 31 December, 2020, Payable on or About 22 June, 2021

Full year 2020 earnings released: EPS HK$0.29 (vs HK$0.24 in FY 2019)

Lung Kee (Bermuda) Holdings Limited to Report Fiscal Year 2020 Results on Mar 26, 2021

What These Trends Mean At Lung Kee (Bermuda) Holdings (HKG:255)

Estimating The Intrinsic Value Of Lung Kee (Bermuda) Holdings Limited (HKG:255)

Here's What Lung Kee (Bermuda) Holdings Limited's (HKG:255) Shareholder Ownership Structure Looks Like

If You Had Bought Lung Kee (Bermuda) Holdings (HKG:255) Shares Three Years Ago You'd Have A Total Return Of Negative 12%

New 90-day high: HK$2.61

What We Learned About Lung Kee (Bermuda) Holdings' (HKG:255) CEO Compensation

Are Dividend Investors Making A Mistake With Lung Kee (Bermuda) Holdings Limited (HKG:255)?

Here's What's Concerning About Lung Kee (Bermuda) Holdings (HKG:255)

New 90-day high: HK$2.50

New 90-day high: HK$2.32

New 90-day high - HK$2.26

First half earnings released

Lung Kee (Bermuda) Holdings Limited to Report First Half, 2020 Results on Aug 28, 2020

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd